Pacira BioSciences Inc.

NASDAQ: PCRXHealthcare / Drugs - Generic / USA
37.16+0.0700+0.19%Vol 389 9351Y Perf -28.54%
Sep 20th, 2019 16:00
BID37.12 ASK37.15
Open37.09 Previous Close37.09
Pre-Market- After-Trading37.20
 - -%  0.04 0.11%
Target Price
52.43 
Analyst Rating
Moderate Buy 2.08
Potencial %
41.09 
Finscreener Ranking
★★★+     52.19
Insiders Trans % 3/6/12M
-100/-100/-84 
Value Ranking
★★     46.34
Insiders Value % 3/6/12M
-100/-100/-94 
Growth Ranking
★★★★     58.57
Insiders Shares Cnt. % 3/6/12M
-100/-100/-94 
Income Ranking
 —    -
Market Cap (mil)1 547 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
12.38 
Earnings Date
7th Nov 2019

Today's Price Range

37.0537.52

52wk Range

34.6455.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-2.60%
1 Month
-5.64%
3 Months
-15.51%
6 Months
-6.52%
1 Year
-28.54%
3 Years
0.95%
5 Years
-63.27%
10 Years
-

Name / TickerPriceChg.Chg.%
PCRX37.160.07000.19
AAPL217.73-3.2300-1.46
GOOG1 229.93-8.7800-0.71
MSFT139.44-1.6300-1.16
XOM72.08-0.2500-0.35
WFC48.63-0.2800-0.57
JNJ131.651.54001.18
FB189.93-0.2100-0.11
GE9.37-0.0500-0.53
JPM118.90-0.4800-0.40
Earnings HistoryEstimateReportedSurprise %
Q02 20190.140.2364.29
Q01 20190.020.04100.00
Q04 20180.070.28300.00
Q03 2018-0.090.11222.22
Q02 2018-0.130.07153.85
Q01 2018-0.15-0.18-20.00
Q04 2017-0.080.18325.00
Q03 2017-0.23-0.1152.17
Earnings Per EndEstimateRevision %Trend
9/2019 QR0.14-30.00Negative
12/2019 QR0.26-33.33Negative
12/2019 FY0.66-14.29Negative
12/2020 FY1.33-3.62Negative
Next Report Date7th Nov 2019
Estimated EPS Next Report0.14
Estimates Count6
EPS Growth Next 5 Years %34.00
Volume Overview
Volume389 935
Shares Outstanding (in ths.)41 635
Trades Count4 072
Dollar Volume26 361 378
Avg. Volume569 619
Avg. Weekly Volume339 305
Avg. Monthly Volume456 566
Avg. Quarterly Volume513 785
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (46.15 %)
6 (46.15 %)
6 (42.86 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (7.14 %)
Hold
7 (53.85 %)
7 (53.85 %)
7 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.08
Moderate Buy
2.08
Moderate Buy
2.07

Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company have launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

CEO: David M. Stack

Teplephone: +1 973 254-3560

Address: 5 Sylvan Way, Parsippany 07054, NJ, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

75%25%

Bearish Bullish

57%43%

Bearish Bullish

50%50%

News